Entry requirements

The International Master's Programme in Innovative Medicine (IMIM) is a collaboration between Uppsala University (Sweden), the University of Groningen (the Netherlands) and Heidelberg University (Germany), where admitted students study year 1 at any partner university and year 2 at either Groningen or Uppsala. This means that there are three possible study plans where special eligibility for IMIM and the involved partner universities must be fulfilled.

Starting at Uppsala University:

A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. The degree must be in biochemistry/chemistry, biology, biomedicine/medicine, biotechnology, cell/molecular biology, genetics, life science, medical sciences or a similar field of study. Also required is documented knowledge in form of:

- courses in biochemistry, cell biology, chemistry, genetics, and molecular biology/-genetics totalling at least 30 credits; and

- knowledge and previous experience of related laboratory work.

Starting at the University of Groningen:

A Bachelor's degree in the fields of biology, pharmacy, life science and technology or (bio)medical sciences.

Starting at Heidelberg University:

A Bachelor's degree with a fixed standard period of study of four academic years (240 ECTS; equivalent degrees may be accepted)

with above-average grades. In exceptional cases, participants of the IMIM programme may be admitted to the programme with a degree worth only 180 ECTS, provided they are able to submit proof that the outstanding 60 ECTS will be earned no later than by the end of the IMIM programme. The degree needs to be in medicine or the life sciences (e.g. biology, biochemistry, pharmaceutical sciences, biomedical sciences, genetics, molecular biology, biotechnology, health sciences or closely related fields). Proven record of academic and extra-curricular excellence as well as research experience. Strong motivation to pursue a career that incorporates translational, biomedical sciences and research.

Additionally, eligibility for IMIM and all three partner universities requires documented knowledge of English with results from an internationally accepted test.

The minimum test scores are:

IELTS (Academic) with an overall score of 6.5 and no less than 6.0 on each section, or Cambridge Certificate of

Proficiency in English (CPE)/ Cambridge Certificate of Advanced English (CAE) with a minimum score of 180.

TOEFL IBT (internet-based test) with an overall score of 90 - no less than 18 on reading and listening, no less than 20 on

spreaking, no less than 21 on writing.

Aims

IMIM aims to create better opportunities for translational medical research, i.e to bridge the gaps between academic basic research, the private sector and medical application by educating the next generation of researchers and entrepreneurs who have the skills and competence to work effectively in various multi- and interdisciplinary settings as well as internationally competitive contexts in academia and the private sector. IMIM is a European collaboration between the universities of Groningen, Heidelberg and Uppsala, aiming to create an international link between academia and industry at the Master's level education. IMIM has joined a number of national and international industry partners to meet the programme's goals of collaboration and innovation. In a broader international network, IMIM also has associated academic partners in additional  regions.

IMIM's ambition is to stimulate students to innovative thinking and encourage entrepreneurship to meet future health care challenges and societal needs. The programme gives students the opportunity to discover, integrate and apply knowledge from various disciplinary areas to solve complex translational problems.

The content of the programme is multidisciplinary, and also aims to reinforce this focus by creating an interdisciplinary composition of students with different academic backgrounds in medicine, biology and pharmacology. The teaching is conducted at the current research frontiers in strong subject areas at the various partner universities.

Collaboration between industry and academia takes place in global competition, and increased international mobility promotes innovation and stimulates the exchange of ideas and knowledge. IMIM prepares students for an international job market by building up students'   broad professional network for working life and research during their education.

Instruction

The teaching consists of lectures, both on campus and online, as well as compulsory seminars, demonstrations, web-based assignments, experimental and theoretical modules, and project work in research laboratories or in companies, study visits, symposia and events. A significant element of teaching consists of student-driven learning and interaction between partner universities. The teaching is performed in English.

Examination

Written tests, assignments and reports also in the form of scientific articles, product/business plan, research plan and applications as well as oral presentations and peer-reviews in seminars or symposia. Strong emphasis is put on independence and showed activity.

Degree

The programme at Uppsala University leads to a Master of Medical Science (120 credits) with Medical Science as main field of study. The student applies for a Double degree from the partner universities where the studies were conducted.